Table 2.
Characteristics of the prescriptions in the first year after index date
| Treatment (no. of users) | No. of scripts | No. of scripts per patient | Average quantity per script (SD) | Average duration per script in days (SD) | Median duration per script in days |
|---|---|---|---|---|---|
| Asacol® and generics (699) |
5994 |
8.6 |
146 (102) |
24.0 (12.8) |
30 |
| Pentasa® (208) |
1627 |
7.8 |
111.7 (92.9) |
19.8 (12.7) |
30 |
| Salofalk® (817) |
7317 |
9.0 |
140.0 (96.8) |
23.0 (14.1) |
30 |
| Mezavant® (147) | 2124 | 14.4 | 77.1 (40.5) | 27.2 (11.7) | 30 |
SD, standard deviation.